Literature DB >> 3838489

Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid.

H Bult, A G Herman, M Rampart.   

Abstract

The effects of methylprednisolone, F(ab')2 fragments of human gamma globulins and rosmarinic acid, an inhibitor of complement activation, were tested on endotoxin-induced haemodynamic and haematological changes in the rabbit. Their effects were compared with complement depletion by cobra venom factor (CVF) pretreatment. The results provide further evidence for the role of complement activation and the concomitant triggering of the arachidonic acid cascade in the early phase of shock. The formation of vasoactive prostanoids (prostacyclin and thromboxane A2), the arterial hypotension and the thrombocytopenia were largely dependent on the presence of the intact complement system. F(ab')2 fragments (150 mg kg-1, i.v.) diminished the second fall in blood pressure to some extent but failed to alter any of the other endotoxin-induced changes. Methylprednisolone (40 mg kg-1, i.v.) given 10 min before endotoxin significantly reduced the activation of complement, the second rise of prostacyclin and the secondary hypotension, but was without effect on the early thromboxane peak of the haematological features of endotoxin shock. Rosmarinic acid (20 mg kg-1, i.v.) may be of potential interest for treatment of septic shock, since the drug suppressed the endotoxin-induced activation of complement, the formation of prostacyclin, both hypotensive phases, the thrombocytopenia and the concomitant release of thromboxane A2. The role of leukocytes and their arachidonic acid metabolites in plasma exudation deserves further investigation, because leukopenia and pulmonary oedema were not complement-dependent and were not affected by any of the treatments. Our results indicate that drugs, interfering with complement activation and/or prostaglandin biosynthesis, may be beneficial in endotoxin shock, provided that they are administered at an early stage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838489      PMCID: PMC1987290          DOI: 10.1111/j.1476-5381.1985.tb12916.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

Review 1.  Inhibition of phospholipase.

Authors:  G J Blackwell; R J Flower
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

2.  Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

Authors:  D T Fearon; S Ruddy; P H Schur; W R McCabe
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

3.  Endotoxin-induced changes in the rabbit's blood picture.

Authors:  Z Konicková; Z Líkovský; L Pávková
Journal:  Physiol Bohemoslov       Date:  1980

4.  Aggregate anaphylaxis in the monkey: attenuation of the pulmonary response by pretreatment with indomethacin.

Authors:  B Revenäs; G Smedegård
Journal:  Circ Shock       Date:  1981

5.  Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.

Authors:  D E Hammerschmidt; J G White; P R Craddock; H S Jacob
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

6.  [Therapy and prophylaxis of experimental staphylococcal nephritis of the rabbit with gamma-globulin and F(ab')2-fragments (author's transl)].

Authors:  H Ronneberger; O Zwisler
Journal:  Arzneimittelforschung       Date:  1979

7.  In vivo and in vitro effects of endotoxin on prostaglandin release from rat lung.

Authors:  N Feuerstein; P W Ramwell
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

8.  The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats.

Authors:  S J Coker; B Hughes; J R Parratt; I W Rodger; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

9.  Prostacyclin is not a circulating hormone.

Authors:  E Christ-Hazelhof; D H Nugteren
Journal:  Prostaglandins       Date:  1981-11

10.  Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

Authors:  D C Morrison; C G Cochrane
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  6 in total

1.  Activation of plasma systems and blood cells by endotoxin in rabbits.

Authors:  N J Jansen; W van Oeveren; B H Hoiting; C R Wildevuur
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Effect of nafazatrom and indomethacin on pulmonary removal of prostaglandin E1 after endotoxin in rabbits.

Authors:  C N Gillis; A M Havill; R Moalli
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

3.  Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytes.

Authors:  A M Verweij-van Vught; B J Appelmelk; A B Groeneveld; M Sparrius; L G Thijs; D M MacLaren
Journal:  Agents Actions       Date:  1987-12

4.  Neuroprotective effects of rosmarinic acid on ciguatoxin in primary human neurons.

Authors:  N Braidy; A Matin; F Rossi; M Chinain; D Laurent; G J Guillemin
Journal:  Neurotox Res       Date:  2013-10-05       Impact factor: 3.911

5.  Prostacyclin biosynthesis and reduced 5-HT uptake after complement-induced endothelial injury in the dog isolated lung.

Authors:  H Bult; J J Heiremans; A G Herman; C M Malcorps; F A Peeters
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

6.  Formation of prostanoids during intravascular complement activation in the rabbit.

Authors:  H Bult; A G Herman; G M Laekeman; M Rampart
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.